Dr. Bertolino, Pres and CMO, is a leading pharmaceutical
Dr. Bertolino, Pres and CMO, is a leading pharmaceutical dermatology executive and recently Senior Director of Dermatology at Pfizer.
He will eventually be instrumental in developing partnerships but his dermatological expertise is precisely what what was needed to guide Prurisol through its current phase of development eventually leading to a partnership with BP who will no doubt prefer to have input (think 2b) if not control over the final approval process in order to influence the FDA approved label and maximize marketing advantage. Dr. B's expertise is precisely what was needed to shepard P to approval or hand it off to BP.
What is less obvious but interesting is the overlap between the epithelium (external skin) and the endothelium or mucosa (internal skin) which is a membrane that lines various cavities in the body including the innermost layer of the gastrointestinal tract (think UP, colitis) and surrounds internal organs. It consists of one or more layers of epithelial cells overlying a layer of loose connective tissue. It is of ectodermal origin and is continuous with the skin at various body openings such as the eyes, ears, inside the nose, inside the mouth, lip, the urethral opening and the anus, frenulum of tongue. These 'skins' serve roughly the same functions in that one protects against intrusion and the other extrusion. Thus IMO Dr. B is precisely the right expert to guide the development of both P and B to multiple successful partnerships should the trials continue as they have to date
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Blasting through the tangled mess of modern power distribution, Hitachi Energy's got something to crow about. They've just been hailed as a Leader in the 2026 IDC MarketScape for their advanced distribution management systems (ADMS). It's a title that's worth the ink, not just for the bragging rights but for what their platform can do for today's utilities—facing down...
Continue Reading
Changes in Leadership: The ALTOUR Shakeup You know, in the travel world, shifts in leadership can be quite the rollercoaster ride. We're talking about some pretty big shoes to fill over at ALTOUR, with Gabe Rizzi stepping back after a decade of driving the company's dynamic evolution. He’s not entirely out of the picture, though. Rizzi’s going to hang around as a...
Continue Reading
Spotlight on Ardelyx: The Legal Smoke Signal Ah, lawsuits. They're like bad weather for companies—sometimes, you know they're coming, and they still hit you hard. Ardelyx's investors who've been in the game from January 13, 2025, to August 6, 2026, are now dealing with just such a storm. What's the Lawsuit Racket? Faruqi & Faruqi, LLP, a securities law firm that seems...
Continue Reading
Setting a New Benchmark in Charity Care Well, hold onto your hats, because Aspen Dental just smashed it out of the park with their latest Day of Service effort, a barnburner of an event held on November 7, 2026. These folks went all out, delivering free dental care to more than 6,400 veterans in a single day—yeah, you read that right. The whole shebang was valued at a...
Continue Reading
NatGold's Bold Move Towards Nasdaq NatGold Digital's aiming to roll the dice on a Nasdaq Capital Market listing isn't just an administrative shuffle. They're talking about stepping into the big leagues with their quirky combo of digital gold mining and asset tokenization. Now, this might sound like just another press release, but trust me, whenever a company sets its...
Continue Reading
Shifts in Power: The Rise of Laminated Busbars Seeing the laminated busbar market trajectory kind of reminds me of watching a slow-boiling pot suddenly erupt. Projected to sprout from $0.31 billion in 2026 to $0.66 billion by 2031, it's like betting on a dark horse in the tech race that's finally hitting its stride. What's Driving Demand in Data Centers? With AI and cloud...
Continue Reading
When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...
Continue Reading
Revenue's down by a hair, but it's not as bleak as it seems. CAE Inc. (NASDAQ:CAE) just put its cards on the table for Q2 of fiscal 2027, and there's a mixed bag for us investors to chew over. Revenue dipped 2.6% year-over-year to $1,204.7 million. But hey, their adjusted EPS has climbed up to $0.33, a step up from $0.28 last year, which is a good sign of something right...
Continue Reading
SolidRun Steers the Future of Industrial AI SolidRun's newest venture appears as bold as a bull in a china shop, shaking up the industrial AI market with a comprehensive product line integrating NXP's i.MX 95 System-on-Modules and NVIDIA's Holoscan. What's the big deal? They're connecting the dots across the entire tech stack under one roof, flattening some hills that...
Continue Reading
Energy Transition: The New Competitive Edge Forget everything you thought you knew about energy as just a line item in an industry ledger. At the heart of the ongoing COP31 gathering in Antalya, Türkiye, is the revelation that energy has morphed into something greater—it's become the battleground for global competitive advantage. Ali Y. Koç didn't mince words when he...
Continue Reading
Management Transformation">
Continue Reading